10x Genomics, Inc. Inventory, Raw Materials and Supplies, Net of Reserves
10x Genomics, Inc. (TXG) had Inventory, Raw Materials and Supplies, Net of Reserves of $16.33 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves · last filed 2026-08-07
- 2026-06-30: Inventory, Raw Materials and Supplies, Net of Reserves $16.33M.
- 2026-03-31: Inventory, Raw Materials and Supplies, Net of Reserves $17.25M.
- 2025-12-31: Inventory, Raw Materials and Supplies, Net of Reserves $16.02M.
- 2025-09-30: Inventory, Raw Materials and Supplies, Net of Reserves $18.93M.
| Period end | Inventory, Raw Materials and Supplies, Net of Reserves |
|---|---|
| 2026-06-30 | $16.33M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $17.25M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $16.02M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $18.93M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $20.54M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $36.18M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $38.93M 10-K · filed 2026-02-13 |
| 2024-09-30 | $38.03M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $38.87M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $39.16M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $34.48M 10-K · filed 2025-02-13 |
| 2023-09-30 | $35.83M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $37.94M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $37.10M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $34.50M 10-K · filed 2024-02-15 |
| 2022-09-30 | $33.42M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $28.29M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $33.91M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $31.95M 10-K · filed 2023-02-16 |
| 2021-09-30 | $26.00M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $19.38M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $14.75M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $9.93M 10-K · filed 2022-02-18 |
| 2020-09-30 | $7.73M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $8.18M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $9.12M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $6.44M 10-K · filed 2021-02-26 |
| 2019-09-30 | $4.37M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $3.05M 10-K · filed 2020-02-27 |